80% of oncologists discuss medical marijuana with patients and nearly half recommend its clinical use but, less than 30% consider themselves knowledgeable enough to make such recommendations,
Cannabinoids including THC found to be effective antibiotics for C. diff, VRE, and a variety of additional pathogens linked to diarrhea and colitis.
Innovations with Ed Begley Jr. set to cover PathogenDx who provide technology for simple, effective, fast, and affordable DNA-based pathogen testing for cannabis, botanicals and food.
Company set to utilize a proprietary technique which involves the activation, purification, and extraction of cannabinoids using only ethanol and other food-grade components.
Strain protection and genetic identification are major issues for growers and breeders but a new technology may now allow them to identify and secure rights to their valuable intellectual property.
Tens of thousands of medical cannabis patients have tracked over 500,000 medical records on Strainprint's mobile patient journal, generating over 7 million data points on strain efficacy and patient use.
The panel discussion covered the barriers to understanding how cannabis can be used to alleviate chronic pain and potentially ease the opioid crisis.
With the launch of the BASInfused™ certified seal, cannabis consumers will be safe in the knowledge that the products they consume are safe and labeled correctly.
“We shared our pain-patch with leading pain doctors in the region and they were all excited”; Preliminary studies on pain-patch shows excellent results” said Bobban Subhadra, M.S., Ph.D, Chief Operating Officer of Apotheca.